Wat vind je van agmantine?
Aanbevolen gebruik:
Neem 750 mg Agmatine per dag. Inname voor de training of voor het slapen gaan.
Wetenschappelijke referenties:
1. Abe K, Abe Y, and Saito H. Agmatine suppresses nitric oxide production in microglia. Brain Res. 872: 141-148, 2000.
2. Aricioglu-Kartal F, and Regunathan S. Effect of chronic morphine treatment on the biosynthesis of agmatine in rat brain and other tissues. Life Sci. 71: 1695-1701, 2002.
3. Gao, Y., et al. Agmatine: a novel vasodilator substance. Life Sciences. 57(8)

L83-86, 1995.
4. Halaris A, Piletz JE. Imidazoline receptors: possible involvement in the pathophysiology and treatment of depression. Hum Psychopharmacol. 16(1):65-69, 2001.
4. Kalra, S.P., et al. Agmatine, a novel hypothalamic amine, stimulates pituitary luteinizing hormone release in vivo and hypothalamic luteinizing hormone-releasing in vivo. Ne uroscience Letters. 194 (3): July 21, 1995; 165-168.
6. Kawabata T, Ohshima H, Ino M. Occurrence of methylguanidine and agmatine in foods. IARC Sci Publ. (19):415-23, 1978.
7. Lortie, M.J., et al. Agmatine, a bioactive metabolite of arginine. Production, degradation, and functional effects in the kidney of the rat. Journal of Clinical Investigation. 97(2):413-420, 1996.
8. Morgan, N.G., et al. Characterization of the imidazoline binding site in regulation of insulin secretion. Annals of the New York Academy of Sciences. 763:361-373, 1995.
9. Nishimura K, Shiina R, Kashiwagi K, and Igarashi K. Decrease in Polyamines with Aging and Their Ingestion from Food and Drink. J of Biochem. 139(1):81-90, 2006.
10. Raasch, W. et al. Agmatine, the bacterial amine is widely distributed in mammalian tissues. Life Sciences. 56(26):2319-2330, 1995.
11. Raghavan SA, Dikshit M. Vascular regulation by the L-arginine metabolites, nitric oxide and agmatine. Pharmacol Res. 49(5):397-414. Review, 2004.
12. Regunathan S, Feinstein DL, and Reis DJ. Anti-proliferative and anti-inflammatory actions of imidazoline agents. Are imidazoline receptors involved? Ann NY Acad Sci. 881: 410-419, 1999.
13. Regunathan S, and Reis DJ. Characteristics of arginine decarboxylase in rat brain and liver: distinction from ornithine decarboxylase. J Neurochem. 74: 2201-2208, 2000.
14. Reis DJ, and Regunathan S. Agmatine a novel neurotransmitter? Advances in Pharmacology. 42:645-649, 1998.
15. Schwartz D, Peterson OW, Mendonca M, Satriano J, Lortie M, and Blantz RC. Agmatine effects glomerular filtration rate via a nitric oxide synthase-dependent mechanism. Am J Renal Physiol. 272: F597-F601, 1997.
16. Sener A, et al. Stimulus-secretion coupling of arginine-induced insulin release. Insulinotropic action of agmatine. Biochemical Pharmacology. January 15, 1989. 38(2):327- 330, 1989.
17. Tabor CW, and Tabor H. Polyamines. Ann Rev Biochem. 53: 749-790, 1984.
18. Vargiu C, Cabella C, Belliardo S, Cravanzola C, Grillo MA and Colombatto S. Agmatine modulates polyamine content in hepatocytes by inducing spermidine/spermine acetyltransferase. Eur. J Biochem. 259: 933-938, 1999.
19. Weitzel G., et al. Insulin-like partial effects of agmatine derivatives in adipocytes. Hoppe-Seylers Zeitschrift fur Physiologische Chemie. 361(1):51-60, 1980.
20. Yananli H, Goren MZ, Berkman K, Aricioglu F. Effect of agmatine on brain l-citrulline production during morphine withdrawal in rats: A microdialysis study in nucleus accumbens. Brain Res. 2007 Feb 9;1132(1):51-58, 2006.
21. Zarandi M, Serfozo P, Zsigo J, Deutch AH, Janaky T, Olsen DB, Bajusz S, Schally AV. Potent agonists of growth hormone-releasing hormone. II. Pept Res. 5(4):190-3, 1992.